Acute Pericarditis (BB20): Complete Guide for Clinical Coding

1. Introduction

Acute pericarditis represents one of the leading causes of chest pain in emergency services and constitutes the most frequently diagnosed pericardial disease in clinical practice. It is an inflammation of the pericardium - the double-layered membrane that surrounds the heart - with a characteristic duration of up to one to two weeks, distinguishing itself from subacute and chronic forms by its specific temporal presentation.

This condition presents significant clinical relevance due to its ability to mimic other cardiovascular emergencies, particularly acute myocardial infarction, making differential diagnosis an essential skill for healthcare professionals. Acute pericarditis can affect individuals of all age groups, although it is more common in young and middle-aged adults, with a slight male predominance.

The impact on public health relates not only to the considerable incidence of the disease, but also to its potential complications when not adequately diagnosed and treated. Unrecognized cases may progress to recurrent forms, constrictive pericarditis, or cardiac tamponade, conditions that demand more complex and prolonged interventions.

Correct coding using the BB20 code from ICD-11 is critical for multiple aspects of health management. It enables appropriate epidemiological tracking, facilitates prevalence and outcome studies, ensures appropriate reimbursement by health systems, contributes to correct allocation of hospital resources, and enables analysis of care quality. Furthermore, accurate documentation is fundamental for continuity of care, especially considering that acute pericarditis presents a significant recurrence rate that requires longitudinal follow-up.

2. Correct ICD-11 Code

The code BB20 from the International Classification of Diseases in its 11th revision specifically designates Acute pericarditis, a condition characterized by inflammation of the pericardium with limited duration.

Code: BB20

Description: Acute pericarditis

Parent category: null - Pericarditis

Official definition: Acute pericarditis is defined as pericardial inflammation lasting up to one to two weeks.

This code is situated within the chapter on circulatory system diseases of ICD-11, specifically in the section dedicated to pericardial diseases. The classification clearly distinguishes the acute form from chronic presentations and other pericardial complications, reflecting the importance of differentiating these entities both for prognostic and therapeutic purposes.

The temporal definition of "up to one to two weeks" is a crucial element that differentiates acute pericarditis from other forms. This temporal delimitation is not arbitrary, but reflects well-established clinical patterns of disease progression and responds to different underlying pathophysiologies. Precise coding allows identification of cases that may require distinct therapeutic approaches and present varied prognoses.

3. When to Use This Code

The code BB20 should be applied in specific clinical situations where there is diagnostic confirmation of acute pericarditis. Below are detailed practical scenarios:

Scenario 1: Patient with Classic Triad of Pericarditis

Patient presenting with acute chest pain of pleuritic character that worsens when lying down and improves when sitting leaning forward, associated with pericardial friction rub on cardiac auscultation and typical electrocardiographic changes (diffuse ST segment elevation and PR segment depression). Echocardiography confirms mild to moderate pericardial effusion without signs of tamponade. Symptoms began five days ago. This is the classic scenario for applying code BB20.

Scenario 2: Confirmed Viral Pericarditis

Patient with recent flu-like illness progressing to characteristic chest pain, fever, and elevation of inflammatory markers. The electrocardiogram shows changes compatible with acute pericarditis and echocardiography identifies pericardial effusion. When viral etiology is confirmed or strongly suspected (post-viral infection) and the condition has duration less than two weeks, BB20 is appropriate and may be complemented with an additional code specifying the etiologic agent when identified.

Scenario 3: Early Post-Myocardial Infarction Pericarditis

Patient who developed pericarditis between 24 hours and several days after acute myocardial infarction (early Dressler syndrome). Presents with chest pain distinct from the original ischemic pain, pericardial friction rub, and electrocardiographic changes characteristic of pericarditis. In this context, BB20 is used as an additional code to the myocardial infarction code, documenting this specific complication.

Scenario 4: Acute Idiopathic Pericarditis

Patient with no identifiable apparent cause presents with acute pericarditis with all diagnostic criteria present. After appropriate investigation excluding secondary causes (autoimmune, neoplastic, specific infectious, uremic), the diagnosis of idiopathic pericarditis is established. When the condition is in the acute phase (less than two weeks), BB20 is the correct code.

Scenario 5: Acute Traumatic Pericarditis

Patient victim of blunt or penetrating thoracic trauma who develops pericarditis in the days following the traumatic event. The pericardial inflammatory condition is confirmed by clinical, electrocardiographic, and echocardiographic criteria. BB20 is applied together with appropriate codes for the trauma, documenting this specific complication.

Scenario 6: Pericarditis in the Context of Systemic Disease

Patient with known autoimmune disease (such as systemic lupus erythematosus) who develops an acute episode of pericarditis. When the pericardial manifestation is acute and meets temporal criteria, BB20 is used as an additional code to the code of the underlying disease, capturing this specific manifestation of the autoimmune process.

4. When NOT to Use This Code

There are specific clinical situations where code BB20 is not appropriate, and alternative codes should be used:

Acute Rheumatic Pericarditis

When acute pericarditis occurs in the context of active rheumatic fever, with evidence of rheumatic carditis, the specific code 869759708 should be used instead of BB20. This distinction is fundamental because rheumatic pericarditis has distinct prognostic, therapeutic, and epidemiological implications, requiring treatment directed at rheumatic fever and prolonged secondary prophylaxis.

Pericarditis with Prolonged Duration

If symptoms persist beyond two weeks or if the patient already presents with chronification of the inflammatory process, BB20 is no longer appropriate. Subacute presentations (two weeks to six months) or chronic presentations (more than six months) require different codes that reflect this distinct temporal evolution.

Established Complications

When the patient has already developed clinically significant cardiac tamponade, the appropriate code is BB23, not BB20. Similarly, if there is evidence of established pericardial constriction, code BB22 should be used. These are distinct entities that, although they may originate from acute pericarditis, represent different pathophysiological processes with specific therapeutic approaches.

Isolated Pericardial Effusion

The presence of pericardial effusion without evidence of active inflammation (absence of pain, pericardial friction rub, electrocardiographic changes, or elevation of inflammatory markers) does not justify the use of BB20. Isolated pericardial effusion has its own code and may have non-inflammatory etiologies.

Recurrent Pericarditis in Non-Acute Episode

Patients with a history of recurrent pericarditis who are in a phase of remission or on prophylactic treatment, without an active acute episode at the time of coding, should not receive BB20. The code should reflect the patient's current status.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The diagnostic confirmation of acute pericarditis is based on well-established clinical criteria. At least two of the following four main criteria are required:

Pericardial chest pain: Characteristically acute, pleuritic, which improves when sitting and leaning forward, and worsens when lying supine. The pain may radiate to the trapezius due to phrenic innervation of the pericardium.

Pericardial friction rub: Friction sound on cardiac auscultation, best heard with the patient leaning forward, and may have monophasic, biphasic, or triphasic components. This sign may be transient and intermittent.

Electrocardiographic changes: Diffuse ST segment elevation (concave upward) with PR segment depression, followed by normalization and subsequent T wave inversion. The changes are typically diffuse, differentiating from the territorial pattern of myocardial infarction.

Pericardial effusion: Identified by echocardiography, usually new or increasing. It may vary from minimal to large, and it is important to assess signs of hemodynamic compromise.

Essential diagnostic tools include serial electrocardiogram, transthoracic echocardiography, measurement of inflammatory markers (C-reactive protein, erythrocyte sedimentation rate) and myocardial injury markers (troponins) to differentiate from myocardial infarction.

Step 2: Verify Specifiers

Temporal duration is the critical specifier for BB20. Confirm that the clinical presentation has a duration of up to one to two weeks from symptom onset. Document the precise date of onset when possible.

Assess the severity of the condition: presence of high fever, large pericardial effusion, lack of response to anti-inflammatory drugs after seven days, and evidence of concomitant myocardial involvement (myopericarditis) are severity indicators that, although they do not change the BB20 code, should be documented to guide treatment and prognosis.

Identify, when possible, the underlying etiology: viral, bacterial, tuberculous, uremic, neoplastic, autoimmune, post-infarction, post-surgical, or traumatic. Although BB20 is used regardless of etiology, additional codes may be necessary to document the specific cause.

Step 3: Differentiate from Other Codes

BB21 - Chronic rheumatic pericarditis: The fundamental difference lies in the etiology (rheumatic fever) and chronicity. BB21 is used for chronic sequelae of rheumatic carditis, while BB20 applies to acute processes of various etiologies. The presence of a history of rheumatic fever and chronic manifestations directs toward BB21.

BB22 - Constrictive pericarditis: Differentiated by the presence of pericardial thickening and calcification with restriction to ventricular filling. It is a chronic process with specific hemodynamic manifestations (Kussmaul sign, prominent Y wave, equalization of diastolic pressures). While BB20 is inflammatory and acute, BB22 represents a chronic fibrotic consequence.

BB23 - Cardiac tamponade: Characterized by significant hemodynamic compromise due to accumulation of pericardial fluid. It presents with Beck's triad (hypotension, jugular venous distension, muffled heart sounds), pulsus paradoxus, and specific echocardiographic signs (diastolic collapse of right chambers). BB23 is used when tamponade is established, while BB20 may have effusion without hemodynamic compromise.

Step 4: Required Documentation

For appropriate coding with BB20, the documentation should include:

Mandatory checklist:

Date of symptom onset and duration of the condition
Detailed description of chest pain (characteristics, location, factors of improvement/worsening)
Presence or absence of pericardial friction rub
Electrocardiogram results with description of changes
Echocardiographic report documenting presence/absence of effusion and its characteristics
Inflammatory and cardiac markers
Etiological investigation performed
Exclusion of main differential diagnoses (myocardial infarction, pulmonary embolism, pneumonia)
Initial therapeutic response when applicable

6. Complete Practical Example

Clinical Case

A 32-year-old patient, previously healthy, presents to the emergency department with a complaint of chest pain that began three days ago. He reports that the pain is acute, localized to the precordial region, with radiation to bilateral cervical region, of moderate to severe intensity. He characterizes the pain as "stabbing," which worsens significantly when lying down, with deep inspiration, and when coughing. He noticed improvement when sitting leaning forward. He denies significant dyspnea at rest, but reports respiratory discomfort due to pain with deep inspiration.

Additional history reveals an upper respiratory tract infection approximately ten days ago, with low-grade fever, rhinorrhea, and cough, which had already improved when the chest pain started. He denies previous comorbidities, does not use regular medications, and denies smoking or illicit drug use.

On physical examination: patient in good general condition, preferring a forward-leaning seated position. Vital signs: blood pressure 125/78 mmHg, heart rate 92 bpm, respiratory rate 18 breaths/min, axillary temperature 37.8°C, oxygen saturation 98% on room air. Cardiac auscultation reveals rhythmic, normal-sounding heart sounds, with the presence of a triphasic pericardial friction rub best heard at the left sternal border with the patient leaning forward. Pulmonary auscultation without abnormalities. Absence of lower extremity edema or pathological jugular venous distension.

Complementary evaluation performed:

Electrocardiogram: sinus rhythm, diffuse concave ST segment elevation in leads DI, DII, aVL, V2-V6, with PR segment depression in multiple leads. Absence of pathological Q waves or territorial alterations suggestive of ischemia.

Transthoracic echocardiogram: preserved left ventricular function (ejection fraction 65%), absence of segmental contractility abnormalities, presence of mild to moderate circumferential pericardial effusion (approximately 8mm in diastole), without signs of hemodynamic compromise or right chamber collapse.

Laboratory tests: complete blood count with mild leukocytosis (11,500/mm³) without left shift, elevated C-reactive protein (45 mg/L), erythrocyte sedimentation rate 38 mm/h, troponin I with mild elevation (0.15 ng/mL, reference value <0.04), normal renal function and electrolytes.

Chest X-ray: slightly enlarged cardiac silhouette, clear lung fields.

Step-by-Step Coding

Analysis of diagnostic criteria:

The patient presents three of the four main criteria for acute pericarditis:

Chest pain with typical characteristics of pericardial pain (pleuritic, positional)
Triphasic pericardial friction rub on auscultation
Electrocardiographic alterations compatible (diffuse ST elevation, PR depression)
Pericardial effusion documented on echocardiogram

The presence of three criteria definitively confirms the diagnosis of acute pericarditis.

Temporal verification:

The condition began three days ago, clearly within the period of up to two weeks that defines the acute phase of pericarditis.

Exclusion of differential diagnoses:

Acute myocardial infarction was excluded by the absence of territorial alterations on ECG, absence of segmental contractility alterations on echocardiogram, and only mild troponin elevation (compatible with mild myopericarditis, without significance of extensive myocardial necrosis).

Pulmonary embolism was considered unlikely due to the absence of significant dyspnea, absence of risk factors, and pain characteristics not suggestive of this condition.

Code selected: BB20 - Acute pericarditis

Complete justification:

The code BB20 is appropriate because the patient presents with pericardial inflammatory condition confirmed by clinical, electrocardiographic, and echocardiographic criteria, with a duration of three days (acute phase), without complications that would justify alternative codes. There is no evidence of cardiac tamponade (absence of hemodynamic compromise), no pericardial constriction (acute condition, not chronic), and no context of rheumatic fever (which would direct to a specific code for rheumatic pericarditis).

The most likely etiology is post-infectious viral, given the preceding upper respiratory tract infection, however no specific agent was identified. This presumed etiology does not alter the main code BB20, but may be documented additionally if desired for epidemiological purposes.

Complementary codes:

No additional mandatory codes are necessary in this case. If there is interest in documenting troponin elevation suggesting a myopericarditis component, an additional code may be considered, but BB20 remains as the appropriate main code.

7. Related Codes and Differentiation

Within the Same Category

BB21: Chronic rheumatic pericarditis

When to use BB21 vs. BB20: BB21 is specific for cases of pericarditis as a manifestation or sequela of rheumatic fever, generally in a chronic context. Unlike BB20, which encompasses acute pericarditis of various etiologies, BB21 is restricted to rheumatic etiology and implies an established or recurrent process related to rheumatic carditis.

Main difference: The etiology (rheumatic fever) and chronology (generally chronic or recurrent in the context of rheumatic disease) are the essential differentiators. Patients with BB21 frequently have a history of prior rheumatic fever, may present with concomitant valvular involvement, and require secondary prophylaxis to prevent new rheumatic episodes.

BB22: Constrictive pericarditis

When to use BB22 vs. BB20: BB22 applies to cases where there is thickening, fibrosis, and frequently calcification of the pericardium, resulting in restriction of ventricular filling. While BB20 represents acute inflammatory process, BB22 is a chronic consequence of various processes (including prior acute pericarditis, tuberculosis, radiation, cardiac surgery).

Main difference: The pathophysiology is fundamentally distinct. BB22 is characterized by permanent structural alterations of the pericardium with hemodynamic manifestations of restriction (equalization of diastolic pressures, restrictive pattern on Doppler), whereas BB20 is a potentially reversible inflammatory process. Treatment also differs radically: BB20 responds to anti-inflammatory agents, while BB22 frequently requires surgical pericardiectomy.

BB23: Cardiac tamponade

When to use BB23 vs. BB20: BB23 is used when there is accumulation of pericardial fluid (or blood, in cases of hemopericardium) in quantity and velocity sufficient to cause significant hemodynamic compromise. While BB20 may present with pericardial effusion without hemodynamic repercussion, BB23 implies a medical emergency requiring urgent intervention.

Main difference: The presence of hemodynamic compromise is the critical differentiator. BB23 presents with hypotension, compensatory tachycardia, pulsus paradoxus, signs of low cardiac output, and echocardiographic evidence of right atrial and ventricular collapse during diastole. BB20 may have large effusion without these signs if accumulation was gradual allowing adaptation. BB23 requires urgent pericardiocentesis, while BB20 is generally managed clinically.

Differential Diagnoses

Acute Myocardial Infarction: May present with chest pain and electrocardiographic changes. Differentiated by typically oppressive pain (not pleuritic), territorial ST changes (not diffuse), significant troponin elevation, and segmental contractility abnormalities on echocardiography.

Pulmonary Embolism: May cause pleuritic chest pain. Distinguished by disproportionate dyspnea, thromboembolic risk factors, absence of pericardial friction rub, and specific ECG changes (S1Q3T3, right bundle branch block) and echocardiographic findings (right ventricular dysfunction).

Aortic Dissection: Presents with acute severe chest pain. Differentiated by sudden onset, "tearing" pain, migratory in nature, frequently with asymmetry of pulses and blood pressure, and specific findings on vascular imaging studies.

8. Differences with ICD-10

In ICD-10, acute pericarditis was coded as I30.9 (Acute pericarditis, unspecified) when the etiology was not determined, or more specific codes such as I30.0 (Acute nonspecific pericarditis), I30.1 (Infectious pericarditis), or I30.8 (Other forms of acute pericarditis) when etiological specification was available.

The main change in ICD-11 with code BB20 is the simplification and unification under a single code for acute pericarditis, regardless of specific etiology, with the possibility of additional codes to document causes when identified. This approach reduces ambiguity in coding and facilitates epidemiological analyses.

ICD-11 also more clearly emphasizes the temporal delimitation (up to one to two weeks) in the code definition itself, something that was less explicit in ICD-10. This temporal precision aids in differentiating between acute, subacute, and chronic forms.

The practical impact of these changes includes greater uniformity in coding across different services and countries, facilitation of comparative studies, and reduction of variability in documentation. Healthcare professionals who used different I30 codes in ICD-10 now converge to BB20, improving the consistency of global health data.

9. Frequently Asked Questions

How is acute pericarditis diagnosed?

The diagnosis is based on the presence of at least two of four main criteria: characteristic chest pain (pleuritic, positional), pericardial friction rub on auscultation, typical electrocardiographic changes (diffuse ST-segment elevation, PR-segment depression), and pericardial effusion on echocardiography. Complementary evaluation includes serial electrocardiography, echocardiography, inflammatory markers (C-reactive protein), and cardiac markers (troponins) to assess concomitant myocardial involvement. Additional etiologic investigation may be necessary depending on the clinical context.

Is treatment available in public health systems?

Yes, treatment of acute pericarditis is widely available in public health systems, as it is primarily based on nonsteroidal anti-inflammatory medications or aspirin in high doses, combined with colchicine, which are relatively inexpensive medications and widely available. Uncomplicated cases can be treated on an outpatient basis, reducing costs. Only situations with complications or high-risk criteria require hospitalization and more intensive monitoring.

How long does treatment last?

Typical treatment of acute pericarditis lasts between two to four weeks. Anti-inflammatory medications are generally maintained for one to two weeks with gradual dose reduction, while colchicine, which significantly reduces the risk of recurrence, is maintained for three months. The duration can be adjusted according to clinical response and normalization of inflammatory markers. Recurrent cases may require more prolonged treatments.

Can this code be used in medical certificates?

Yes, code BB20 can and should be used in medical certificates when appropriate, adequately documenting the condition that justifies absence from work or other activities. Acute pericarditis frequently requires temporary leave, especially in the first weeks when pain is more intense and there is risk of complications. The duration of leave varies according to severity, response to treatment, and the nature of the patient's professional activities.

What are the warning signs that indicate complications?

Warning signs include: persistent fever above 38°C, lack of response to anti-inflammatory medications after seven days of adequate treatment, development of progressive dyspnea, hypotension, disproportionate tachycardia, appearance of jugular venous distension, pulsus paradoxus (drop in systolic blood pressure >10mmHg during inspiration), or progressive increase in pericardial effusion on echocardiography. These signs may indicate progression to cardiac tamponade or other complications that require urgent evaluation.

Can acute pericarditis recur?

Yes, recurrence is relatively common, occurring in a significant proportion of cases, especially when initial treatment is inadequate or discontinued prematurely. The use of colchicine during the first episode substantially reduces the risk of recurrence. Recurrences are defined as new episodes after a symptom-free period of at least four to six weeks. Cases with multiple recurrences may require more prolonged treatments or specific immunosuppressive therapies.

Is restriction of physical activities necessary?

Yes, restriction of physical activities is recommended during the acute phase and until complete resolution of symptoms and normalization of inflammatory markers. Intense exercise should be avoided for at least three months in uncomplicated cases, or up to six months in cases with evidence of myopericarditis (troponin elevation). This restriction aims to prevent complications and recurrences. Gradual return to activities should be guided by a healthcare professional.

What is the difference between pericarditis and myopericarditis?

Myopericarditis refers to concomitant involvement of the pericardium and myocardium, evidenced by significant elevation of myocardial injury markers (troponins) and/or alterations in ventricular contractility on echocardiography. While isolated pericarditis (BB20) has an excellent prognosis, myopericarditis may present a more prolonged course and requires more careful monitoring. Treatment is similar, but restriction of physical activities is more rigorous and prolonged in myopericarditis.

Conclusion

Code BB20 from ICD-11 for acute pericarditis represents an essential tool for accurate documentation of this common cardiovascular condition. Correct application of this code requires clear understanding of diagnostic criteria, adequate temporal delimitation, and careful differentiation from other pericardial conditions and differential diagnoses. Appropriate coding not only facilitates administrative and epidemiological management, but fundamentally contributes to quality of patient care by ensuring accurate documentation, effective communication among professionals, and adequate continuity of care in this condition that, although generally benign, requires careful monitoring due to the risk of recurrences and potential complications.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Acute Pericarditis

Compartir